Pathology Home Diagnostic Tests Consultations faculty index Fellowships index Research index Residency index
Sakir Humayun Gultekin, MD
Neuropathologist and Surgical Pathologist; Director, Neuromuscular Pathology Laboratory; Program Director, Pathology Residency Program
Rank: Associate Professor
Clinical Services: Neuropathology, Surgical Pathology
Clinical Interests: Neuropathology, General Surgical Pathology, Oncologic Surgical Pathology, Medical Legal Pathology, Brain and Spinal Cord Tumors, Pituitary Pathology, Skeletal Muscle and Peripheral Nerve
Research Interests: Development of Tissue Markers in Neuro-oncology Diagnosis Paraneoplastic Neurological Syndromes
1986    MD, Hacettepe University Medical School, Ankara, Turkey
1991    Istanbul University Dept. of Neurology, Neurology residency
1993    Neuropathology Fellow, UMass & Brigham & Women's Hospitals
1995    Anatomic Pathology resident, New York Hospital Cornell Medical Center
1996    Experimental Pathology Fellow, Memerial Sloan-Kettering Cancer Center (MSKCC)
1997    Oncologic Surgical Pathology Fellow, MSKCC
2000    Senior Research Fellow in Molecular Neuro-oncology, MSKCC
1999    Anatomic Pathology
1999    Neuropathology
Previous Position:
2000-2004  Assistant Professor of Pathology, Mount Sinai Medical School, New York, NY
2000-2002  Visiting Investigator, MSKCC, Dept. of Neurology, Cotzias Laboratory of Neuro-oncology, New York, NY
Selected References:
  • Dillard TH, Gultekin SH, Delashaw JB Jr, Yedinak CG, Neuwelt EA, Fleseriu M. Temozolomide for corticotroph pituitary adenomas refractory to standard therapy. Pituitary. 2011 Mar;14(1):80-91.
  • Gultekin SH. Paraneoplastic myopathy. Clin Adv Hematol Oncol. 2011 Jul;9(7):561-2.
  • Barrows BD, Rutkowski MJ, Gultekin SH, Parsa AT, Tihan T. Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma. Turkish J Pathology. 2012;28(2):95-103.
  • Brzana JA, Yedinak CG, Delashaw JB, Gultekin HS, Cook D, Fleseriu M.Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH orIGF-1 values? Pituitary. 2012 Dec;15(4):562-70.
  • Azimian M, Gultekin SH, Hata JL, Atkinson JB, Ely KA, Fuchs HA, Mobley BC.Fatal antimalarial-induced cardiomyopathy: report of 2 cases. J Clin Rheumatol.2012 Oct;18(7):363-6.
  • Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M. Growth hormonegranulation pattern and somatostatin receptor subtype 2A correlate withpostoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary. 2012 Nov 27. [Epub ahead of print] PubMed PMID:23184260.
  • Daniels BH, McComb RD, Mobley BC, Gultekin SH, Lee HS, Margeta M. LC3 and p62 as Diagnostic Markers of Drug-induced Autophagic Vacuolar Cardiomyopathy: A Study of 3 Cases. Am J Surg Pathol. 2013 Jul;37(7):1014-21
  • Selden NR, Al-Uzri A, Huhn SL, Koch TK, Sikora DM, Nguyen-Driver MD, Guillaume DJ, Koh JL, Gultekin SH, Anderson JC, Vogel H, Sutcliffe TL, Jacobs Y, Steiner RD. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. J Neurosurg Pediatr. 2013 Jun;11(6):643-52.
  • Hameed N, Yedinak CG, Brzana J, Gultekin SH, Coppa ND, Dogan A, Delashaw JB,Fleseriu M. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience. Pituitary. 2012 Dec 15. [Epub ahead of print]

Last Updated: 02/17/2010